NSRX Key Statistics, Chart & Performance
The current stock price of NSRX is 7 USD. In the past month the price decreased by -6.7%.
NSRX Latest News, Press Relases and Analysis
NSRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 50.22 | 1.05T | ||
| JNJ | JOHNSON & JOHNSON | 20 | 499.88B | ||
| MRK | MERCK & CO. INC. | 11.88 | 261.34B | ||
| PFE | PFIZER INC | 8.03 | 146.18B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.51 | 100.25B | ||
| ZTS | ZOETIS INC | 20.14 | 56.59B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.69 | 23.23B | ||
| VTRS | VIATRIS INC | 4.57 | 12.40B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.28 | 11.58B | ||
| CORT | CORCEPT THERAPEUTICS INC | 90.68 | 8.39B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.53B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.52B |
Related stock screener links
About NSRX
Company Profile
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. The firm conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The firm's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
Company Info
NASUS PHARMA LTD
Yigal Alon 65
TEL AVIV-YAFO IL
Employees: 0
Phone: 97237326616
NASUS PHARMA LTD / NSRX FAQ
What does NASUS PHARMA LTD do?
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. The firm conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The firm's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
What is the stock price of NASUS PHARMA LTD today?
The current stock price of NSRX is 7 USD. The price decreased by -3.45% in the last trading session.
What is the dividend status of NASUS PHARMA LTD?
NSRX does not pay a dividend.
What is the ChartMill rating of NASUS PHARMA LTD stock?
NSRX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the market expecting NSRX stock to perform?
7 analysts have analysed NSRX and the average price target is 22.44 USD. This implies a price increase of 220.57% is expected in the next year compared to the current price of 7.
What is NASUS PHARMA LTD worth?
NASUS PHARMA LTD (NSRX) has a market capitalization of 63.07M USD. This makes NSRX a Micro Cap stock.
NSRX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NSRX.
NSRX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NSRX. NSRX has a bad profitability rating. Also its financial health evaluation is rather negative.
NSRX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -442.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NSRX Forecast & Estimates
7 analysts have analysed NSRX and the average price target is 22.44 USD. This implies a price increase of 220.57% is expected in the next year compared to the current price of 7.